← Evidence map

ReviewCureus2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Soroush Ansari Lari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization. | OpenQuestion